RxDoctor Payments Data

Charles McDonald, NP

Family · Cheraw, SCNPI 1164061834

Payments from drug & device makers

$1,644in general payments, 2019–2025

Across 106 payments — averaging $15.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$147
  • Ferring Pharmaceuticals Inc.$135
  • AbbVie$123
  • Novo Nordisk$114
  • Fidia Pharma USA Inc.$103
  • AstraZeneca$73
  • plus $950 from 24 others

What the payments were for

  • Food & beverage$1,644100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,644 in reported general payments places this provider in the 75th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$200,220
Medicare patients
560
Services billed
11,889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban49$28,811
Diclofenac Sodium124$2,934
Gabapentin284$1,561
Lidocaine15$1,154
Diclofenac Sodium ErDiclofenac Sodium26$1,124
Methylprednisolone123$985
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen141$947
Meloxicam278$729
Celecoxib51$577
Cyclobenzaprine Hcl44$279
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen40$273
Ibuprofen20$172
Naproxen18$169
Tizanidine Hcl23$154
Tramadol Hcl59$109

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$56$28,81149 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,248 family providers in South Carolina.

Other family in Cheraw

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →